1

WCN2013 SCIENTIFIC SESSIONS as of May 30, 2013

Main Topic 1 (Sun 22/9) Epilepsy (convenor: Pete Engel (USA) MT1.1 (09:00 - 10:30) Session 1: Diagnosis and Management of Epilepsy in Resource-limited settings (chair: Gretchen Birbeck) Knowledge gaps, research needs and the role of international collaborations

Gretchen Birbeck (Zambia, Malawi & US) Insights gained through the china demonstration project

D Zhou (China) An update on measuring the global burden of epilepsy: the 2005 Global Burden of Disease study methods and results

Ana-Claire Meyer (Kenya & US) Establishing epilepsy care services in Iran

Aliakbar Asadi-Pooya (Iran) MT1.2 (11:00 - 12:30 ) Session 2: Epilepsy genetics: new insights change clinical practice (chair: Ingrid Scheffer) Adult patients with epileptic encephalopathies: not too late to make a genetic diagnosis

Ingrid Scheffer (Australia) Monogenic focal epilepsies - new genes change the playing field

Arn van den Maagdenberg (Netherlands) The expanding epilepsy spectrum of GLUT1 deficiency

Peter de Jonghe (Belgium)

MT1.3 (14:30 - 16:00) Session 3: Status Epilepticus (chair: Simon Shorvon) The inflammatory and immunological causes of status epilepticus

Josep Dalmau (USA)

Treatment of acute epilepsy and early status Uri Kramer (Israel)

Subtle status in the ICU after cerebral anoxia - is it status and should it be treated? Andrea Rossetti (Switzerland)

Treatment of refractory status Simon Shorvon (UK)

MT1.4 (16:30 - 18:00 ) Session 4: Surgical treatment for epilepsy (chair: Jerome Engel, Jr.) Who should be referred for surgical therapy?

Jerome Engel, Jr. (US) Benefits of surgical therapy

Samuel Wiebe (Canada) Minimum requirements for an epilepsy surgery center

Kurupath Radhakrishnan (India) The impact of governmentally sponsored epilepsy surgery centers

Andre Palmini (Brazil)

2

Main Topic 2 (Wed 25/9) Movement Disorders (convenors: Günther Deuschl / Erik Ch. Wolters)

Joint Movement Disorders Society / World Federation of Neurology Sessions

MT2.1 (09:00 - 10:30) Session 1: Diagnosing Parkinson’s Disease – evolving concepts (chair: Guenther Deuschl, Germany)

Joint World Federation of Neurology / Movement Disorders Society Session

Parkinson’s disease revisited Erik Ch. Wolters (Netherlands)

The concept of mild cognitive impairment in Parkinson’s disease Bruno Dubois (France)

Global burden of Parkinson’s disease Carolyn Tanner (USA)

The spectrum of non-motor disturbances in Parkinson’s disease and their diagnosis Ray ChaudhurI (GB)

MT2.2 (11:00 - 12:30) Session 2: Latest developments in the treatment of Parkinson’s disease (chair: Erik Wolters, Netherlands)

Recent developments of medical management for Parkinson’s disease Regina Katzenschlager ( Austria)

Recent developments of surgical therapy for Parkinson’s disease Ryan UittI (USA)

Treatment of affective and psychotic disorders in Parkinson’s disease Paolo Barone ( Italy)

Treatment of autonomic disturbances in Parkinson’s disease Pramod Pal ( India)

MT2.3 (14:30 - 16:00) Session 3: Update on atypical Parkinsonism (chair: Werner Poewe , Austria)

Recent advances in PSP Irene Litvan (USA)

A molecular dissection of atypical parkinsonism: X-linked dystonia-parkinsonism Ryuji Kaji (Japan)

Diagnostic tools for the diagnosis of atypical Parkinsonism Klaus Seppi (Innsbruck, Austria)

Strategies for treatment of atypical Parkinsonism Kalyan B. Bhattacharyya (India)

MT2.4 (16:30 - 18:00) Session 4: Recent advances in Movement Disorders (chair: Ryan Uitti / USA ) What is essential tremor?

Guenther Deuschl (Germany) New concepts of dystonia

Victor Fung (Australia)

Diagnostic work-up of choreas Francisco Cardoso (Brasil)

The spectrum of ataxias Alexandra Durr (France)

3

Main Topic 3 (Mon 23 + Tue 24/9) Stroke (Joint World Federation of Neurology/World Stroke Organization Session) (convenors: Bo Norrving /

Michael Brainin) Joint World Federation of Neurology/World Stroke Organization Sessions

MT3.1 (11:15 - 12:45) Session 1: Acute stroke therapies: current status and future directions (chair: Heinrich Mattle / Sandercock) Thrombolytic therapy for stroke: are there residual uncertainty areas?

Peter Sandercock (UK) Endovascular therapy for stroke - for whom, by whom?

Heinrich Mattle (Switzerland) Imaging issues in acute stroke therapies

Stephen Davis (Australia) Intrinsic and extrinsic brain protection strategies

Ulrich Dirnagl (Germany) MT3.2 (14:45 - 16:15) Session 2: Stroke in the Young (chair: Bo Norrving/ Marc Fisher )

Novel insights in causes of juvenile stroke: diagnostic and therapeutic implications Bo Norrving (Sweden)

CADASIL - the continuation of the story Hugues Chabriat (France)

Stroke related to pregnancy José Ferro (Portugal)

Childhood strokes: clinical spectrum and management Gabrielle deVeber (Canada)

MT3.3 (16:45 - 18:15) Session 3: Stroke recovery and rehabilitation (chair: Michael Brainin / Steven Cramer)

Brain recovery strategies Steven Cramer (USA)

Stem cell based therapies for stroke - how far from the bench? Zaal Kokaia (Sweden)

Can we predict recovery potential after stroke? Cathy Stinear (New Zealand)

Organization of stroke rehabilitation services Michael Brainin (Austria)

MT3.4 (Tues 24/9: 09:00 - 10:30) Session 4: Global burden of stroke (chair: Valery Feigin / Jayaraj Pandian)

Trends in stroke incidence, prevalence and survival Valery Feigin (New Zealand)

Regional differences in stroke subtypes and aetiologies: why do they exist? How do they affect therapy? Lawrence Wong (China)

Socioeconomical factors and stroke Gustavo Saposnik (Canada)

Stroke services in low resource settings Jeyaray Pandian (India)

4

Main Topic 4 (Wed 25/9) Neurocritical Care (convenors: Erich Schmutzhard/J. Claude Hemphill / Stefan Schwab)

MT4.1 (09:00 - 10:30) Session 1: Acute Brain Injury, beyond ICP and CPP (chair: Claude Hemphill)

Monitoring in acute Brain Injury John Stover (Switzerland)

Brain Oxygen Monitoring Claude Hemphill (USA)

Cerebral Microdialysis Raimund Helbok (Austria)

Continuous EEG and Monitoring Jan Claassen (USA)

MT4.2 (11:00 - 12:30)Session 2: Neurocritical Care in Stroke (chair: Stefan Schwab (Germany)

Aneurysmal Subarachnoid Hemorrhage Erich Schmutzhard ( Austria)

Intracerebral Hemorrhage Thorsten Steiner ( Germany)

Ischemic Stroke Stefan Schwab ( Germany)

Sinus venous thrombosis Usha Kant Misra ( India)

MT4.3 (14:30 - 16:00) Session 3: Neurocritical Care in Neuromuscular Diseases (chair: Richard Hughes)

Myasthenic crisis Abhijit Chaudhuri (Romford, UK)

Guillain Barré Syndrome Richard Hughes (London, UK)

Tetanus and Botulism Tom P. Bleck (Charlottesville, USA)

Critical illness polyneuropathy and myopathy Nicola Latronico (Brescia, Italy)

MT4.4 (16:30 - 18:00) Session 4: Brain Death and the Concept of Brain Death across regions and cultures (chair: Erich Schmutzhard) Europe

Frank Erbguth ( Germany) Middle East and Africa

Mohammed El-Tamawy ( Egypt)

Asia and Australia Michelle Irving (Australia)

Americas Eelco Wijdicks ( USA)

Main Topic 5 (Tue 24/9) Dementia (convenors: Raul L. Arizaga/ Murat Emre)

Presented by the World Federation of Neurology's Applied Research Group on Dementia MT5.1 (09:00 - 10:30) Session 1: Biomarkers: Rethinking Alzheimer’s Disease (chair: Murat Emre (Turkey))

PET and amyloid markers Kejal Kantarci (USA)

CSF and blood biomarkers Kaj Blennow (Sweden)

Structural and functional MRI in early cognitive impairment Giovanni Frisoni (Italy)

5

MT5.2 (11:00 - 12:30) Session 2: Alzheimer’s Disease: Diagnostic Update (chair: Raul Arizaga (Argentina) Why new criteria in Alzheimer’s Disease?

Raul Arizaga (Argentina) New Criteria in Alzheimer’s disease

Bruno Dubois (France) Alzheimer’s disease diagnosis in the developing world

Adesola Ogunniyi [Nigeria]

MT5.3 (14:30 - 16:00) Session 3: Update in non AD dementias (chair: Vladimir Hachinski, Canada) Frontotemporal dementia

Martin Rossor (UK) Lewy Body Dementia and Parkinson Disease Dementia

Murat Emre (Turkey) Vascular Dementia – new concepts

Vladimir Hachinski (Canada)

MT5.4 (16:30 - 18:00) Session 4: Pathophysiological mechanisms in dementia: an update (chair: Sandra Black, Canada)

Protein aggregations Maria Grazia Spillantini (UK)

Vascular factors in neurodegeneration Sandra Black (Canada)

Genetic causes; monogenic causes and risk genes John Hardy (UK)

Main Topic 6 (Tue 24/9) Multiple Sclerosis and Demyelinating Diseases (convenors: William Carroll / Kazuo Fujihara) Joint International Multiple Sclerosis Federation/ World Federation of Neurology Sessions

MT6.1 (09:00 - 10:30) Session 1: Update on Clinical Subtypes and Diagnosis of Multiple Sclerosis (chairs: Kazuo Fujihara, Jerome de Seze)

Diagnostic Criteria of Multiple Sclerosis Chris Polman (Netherlands)

Progressive Multiple Sclerosis Alan Thompson (UK)

Paediatric Multiple Sclerosis: its uniqueness and implications for adult Multiple Sclerosis Brenda Banwell (Canada)

Differential Diagnosis of Multiple Sclerosis Kazuo Fujihara (Japan)

MT6.2 (11:00 - 12:30) Session 2: Frontiers in Pathogenesis of Multiple Sclerosis (chair: Reinhard Hohlfeld)

Neuropathology of Multple Sclerosis Hans Lassmann (Austria)

Immunological Abnormalities in Multlple Sclerosis Reinhard Hohlfeld (Germany)

The effect of interaction of environment and genes on epidemiology of Multiple Sclerosis George Ebers (UK)

Role of infections in the pathogenesis of Multiple Sclerosis Jorge Correale (Argentina)

MT6.3 (14:30 - 16:00) Session 3: Emerging Multiple Sclerosis Treatment Strategies (chair: Alan Thompson; William Carroll)

Overview William Carroll (Australia)

Pathophysiological insights with Advanced Imaging of Multiple Sclerosis Jeroen Geurts (Netherlands)

6

Difficult to Treat MS – Aggressive, Progressive, Paediatric and Late Onset Forms Bernd Kieseier (Germany)

Over the Horizon therapies Richard Ransohoff (USA)

MT6.4 (16:30 - 18:00) Session 4: Neuromyelitis Optica (chair: Brian Weinshenker / Kazuo Fujihara)

Clinical Spectrum of Neuromyelitis Optica Brian Weinshenker (USA)

Anti-aquaporin 4 antibody: detection methods and pathogenetic implications Paddy Waters (UK)

Immunopathology of neuiromyelitis optica Tatsuro Misu (Japan)

Current, Future and Symptomatic Therapies of NeuroMO Jerome de Seze (France)

Main Topic 7 (Mon 23 + Tue 24/9) Neuromuscular disorders [convenors ‘Eduardo Nobile-Orazio, Michael Shy , Ichizo Nishino]

MT7.1 (11:15 - 12:45) Session 1: Advances in inflammatory neuropathies Joint Peripheral Nerve Society / World Federation of Neurology Session

Guillain Barré Syndrome Peter van Doorn, The Netherlands

Chronic inflammatory demyelinating polyradiculoneuropathy. Eduardo Nobile-Orazio, Italy (Chair)

Multifocal Motor Neuropathy. David Cornblath, Baltimore, USA

Neuropathy and monoclonal gammopathy: Jean Marc Leger, France

MT7.2 (14:45 - 16:15) Session 2: Advances in Inherited neuropathies Joint Peripheral Nerve Society / World Federation of Neurology Session Understanding the pathomechanisms of inherited peripheral neuropathies:

Vincent Timmermann, Belgium

Clinical phenotype of genetic neuropathies: Mary Reilly, UK

Nerve conduction studies in the diagnosis of inherited neuropathy. Richard Lewis, (USA)

Therapeutic perspectives in genetic neuropathies: Michael Shy. US (Chair)

MT7.3 (16:45 - 18:15) Session 3: Muscle Disorders chairs: Zohar Argov ( Israel), Shri K Mishra, (USA) Modern genetic treatments of muscular dystrophies

Thomas Voit (France)

Clinical, genetic and imaging characteristics of LGMD Mayana Zatz (Brazil)

Clinical, genetic and imaging characteristics of distal myopathies Bjarne Udd (Finland)

Iatrogenic myopathies Zohar Argov (Israel)

MT7.4 (24/9: 11:00 - 12:30) Session 4: Muscle Disorders (chair: Ichizo Nishino / Japan)) Recent advances in metabolic myopathy

Ichizo Nishino (Japan) Recent advances in myotonic disorders

Charles Thornton (US)

7

Recent advances in congenital myasthenic syndrome Hanns Lochmuller (UK)

Recent advances In inflammatory myopathy Frank Mastaglia (Australia)

Main Topic 8 (Sun 22/9) Headache (convenors: Stephen Silberstein / Shuu-Jiun Wang) A presentation of the World Federation of Neurology’s Applied Research Group on Headache MT8.1 (09:00 - 10:30) Session 1: Chronic Migraine (chair: Stephen Silberstein (USA)

Pathophysiology of chronic headache Peter Goadsby (London, USA)

Diagnosis and classification Stephen Silberstein (USA)

Pharmacologic Treatment David Dodick (USA)

Neuromodulation Jean Schoenen (Belgium)

MT8.2 (11:00 - 12:30) Session 2: Important headache issues (chair: Shuu-Jiun Wang (Tawain) Worrisome headaches in the third world

K. Ravishankar (India) Migraine comorbidities

Mario Peres (Brazil) Trigeminal Autonomic Cephalalgias

Hans Christoph Diener (Germany) Acupuncture for Headache treatment

Shuu-Jiun Wang (Tawain)

MT8.3 (16:30 - 18:00) Session 3: Responding to the Global Burden of Headache (chair: Timothy Steiner (UK) Joint Lifting the Burden / World Federation of Neurology Session Global Burden of Headache

Timothy Steiner (UK) Cost of headache disorders and can they be reduced?

Mattias Linde (Norway) Epidemiology of headache in Asia

Shuu-Jiun Wang (Tawain) Headache service in developing countries

Zaza Katsarava (Germany)

Main Topic 9 (Sun 22/9) Pain (convenor: Giorgio Cruccu)

MT9.1 (14:30 - 16:00) Session 1: Updating the treatment guidelines for neuropathic pain (chair: Nadine Attal (France) Majia Haanpaa(Finland) The latest EFNS and NeuPSIG treatment guidelines

Majia Haanpaa (Finland) Novel drugs at the horizon

Nadine Attal (France) Advances in neurostimulation therapy

Giorgio Cruccu (Italy)

8

MT9.2 16:30 - 18:00 Session 2: “Sensory profiles” in chronic pain: from symptoms to mechanism and possibly to targeted treatment (chair: Giorgio Cruccu (Italy) The “sensory profile” theory

Ralf Baron (Germany) Support from basic neuroscience

Didier Bouhassira (France) Support from clinical neurophysiology

Andrea Truini (Italy)

Main Topic 10 (Sun 22/9) Neurorehabilitation (convenors: Stephanie Clarke (Lausanne, Switzerland)

Joint World Federation of Neurorehabilitation /World Federation of Neurology Sessions MT10.1 (09:00 - 10:30) Session 1: Motor and cognitive neurorehabilitation

Shaping plasticity to enhance recovery after injury Randolph J Nudo ( USA)

Motor rehabilitation: outcome and evidence Gert Kwakkel (Netherlands)

Neurostimulation of language training Stefano Cappa (Italy)

Neural plasticity underlying recovery from neglect Stephanie Clarke (Switzerland)

MT10.2 (11:00 - 12:30) Session 2: Disease specific neurorehabilitation

Axon regeneration in the injured Central Nervous System Michael Selzer (USA)

Translational research in spinal cord injury: how to overcome the gap? Armin Curt (Switzerland)

Functional imaging before and after epilepsy surgery: a model for neural plasticity Matthias J Koepp (UK)

Cerebral palsy Lucia Willadino Braga (Brazil)

9

Topic 1 (Wed 25/9) T1 Neurooncology (convenors: Wolfgang Grisold, Lisa M. DeAngelis)

Chairs: Lisa M. DeAngelis (USA), Michael Weller (Switzerland)

CNS lymphoma – recent developments in diagnosis and treatment

Lisa M. DeAngelis (USA)

Tumors outside the brain

Wolfgang Grisold (Austria)

The vanishing role of whole brain radiotherapy in neurooncology

Riccardo Soffietti (Italy)

Anti-angiogenesis in glioblastoma therapy

Michael Weller (Switzerland)

Topic 2 (Sun 22/9) CNS infections (convenors: Sarosh M. Katrak, Ahmed Bhigjee)

T2.1 Session 1: (chair: Sarosh M. Katrak (India)

Measles Virus and the Nervous System

Diane E. Griffin (USA)

Stem cell and Solid Organ Transplant – induced CNS Infection

Sarosh M Katrak (India)

Changing Clinical Scenarios in TBM

Dorothee Heemskerk

T2.2 Session 2: : (chair: Ahmed Bhigjee (South Africa)

HTLVI associated myelopathy

Ahmed Bhigjee (South Africa)

Spinal schistosomiasis

Teresa C A Ferrari (Brazil)

Management of cryptococcal meningitis with special reference to complications

David Clifford (USA) Vasculitis and Strokes in CNS Tuberculosis

P Satish Chandra (Bangalore, India)

Topic 3 (Thu 26/9) Sleep (convenors: Antonio Culebras / Madeleine Grigg-Damberger) A Presentation of the World Federation of Neurology’s Applied Research Group on Sleep

T3.1 Session 1: (chair: Antonio Culebras, Birgit Hoegl)

Narcolepsy – an update

Claudio Bassetti (Switzerland)

Case studies in non-REM parasomnias

Carlos Schenck (USA)

Nocturnal frontal lobe epilepsy: differential diagnosis

Liborio Parrino (Italy)

Sleep, sleepiness, and REM sleep behavior disorder in Parkinsonian degenerative disorders

Claudia Trenkwalder (Germany)

T3.2 Session 2: (chair: Madeleine Grigg-Damberger, Claudio Bassetti)

Sudden Death in Sleep Syndromes Neurologists Need to Know

Madeleine Grigg-Damberger (USA)

Vascular complications of sleep apnea

Antonio Culebras (USA)

10

Restless legs syndrome

Birgit Hogl (Austria)

Neurogenic hypersomnias

Yuichi Inoue (Japan)

Topic 4 (Mon 23/9) Leukoencephalopathies and Child Neurology T4.1 Session 1: Leukoencephalopathy session (chair: Jo Wilmshurst) Joint International Child Neurology / World Federation of Neurology SessionNew forms of leukodystrophy

Marjo van der Knaap (Amsterdam)

Leukodystrophies related to systemic disease e.g. malnutrition, vitamin deficiencies, coeliac disease, toxins, SLE, hypertension etc

Banu Anlar (Turkey)

Leukodystophies related to neuroinfections in children e.g. HIV, PML, CMV

Jo Wilmshurst (South Africa)

Mitochondrial diseases mimicking leukodystrophies

Ingrid Tein (Canada)

T4.2 Session 2: Child Neurology (chair: Charles Newton, Kenya)

Joint International Chyild Neurology / World Federation of Neurology Session Stroke mimics and differential diagnoses

Vijeya Ganesan (United Kingdom)

Metabolic neuropathies in childhood

Robert Ouvrier (Australia)

Ethics in child neurology

Charles Newton (Kenya)

Epilepsy and cognition

Lieven Lagae (Belgium)

T4.3 Session 3: (WFN/ILAE/ICNA) Infantile epilepsies: where are we going from here? (chair: Solomon l. Moshe, USA) Joint International League Against Epilepsy / International child Neurology Association / World Federation of Neurology Session Infantile epilepsy guidelines

Jo Wilmshurst ( South Africa)

Infantile seizures and their comorbidities

Lieven Legae (Belgium)

Infantile epilepsies; from the clinic to the basics and beyond

Solomon l. Moshe [USA]

Topic 5 (Mon 23/9) T5 Autoimmune Encephalitis (Convener: Josep Dalmau, Spain)

(Chairs: Josep Dalmau, Spain / Angela Vincent, UK )

Basal ganglia encephalitis and autoimmune movement disorders in children

Russell Dale (Australia)

Autoimmune encephalitis in Japan

Takahiro Iizuka (Japan)

Spectrum of symptoms and cellular and synaptic mechanisms of NMDA and other autoimmune encephalitis

Josep Dalmau (Barcelona)

Encephalitis and antibodies to VGKC-related proteins

Angela Vincent (UK)

11

Topic 6 (Sun 22/9) Neurology, Health Economics, and Outcomes (Convenor: Barbara Vickrey USA)

T6 Session (Chair: Barbara Vickrey)

Health Economics – Basics for Neurologists

Richard Dodel, Germany NICE epilepsy guidelines: outcomes, quality standards and performance

Tony Marson (UK)

Approaches to assessing outcomes and health care utilization using population based data and challenges in cross-national

studies Nathalie Jette (USA)

Accessibility of treatments, and the neurologist-patient dialogue

Barbara Vickrey (USA)

Topic 7 (Tue 24/9) T7 Mitochondrial diseases (Convenor: Laurence Bindoff)

(Chair: Laurence Bindoff, Norway)

New directions in understanding mitochondrial diseases in children

Anu Wartiovaara (Finland)

Treatable mitochondrial diseases affecting the nervous system

Michio Hirano (USA)

Mitochondria and neurodegeneration

Laurence Bindoff (Norway)

Topic 8 (Wed 25/9) T8 (11:00 - 12:30) Neuroepidemiology (convenors: Giancarlo Logroscino, Italy, Valery Feigin, New Zealand) A presentation of the World Federation of Neurology’s Applied Research Group on Neuroepidemiology

(Chairs: Giancarlo Logroscino, Italy / Valery Feigin, New Zealand)

The Study of Alzheimer's Disease in New York and Santo Domingo: same phenotype different genotype?

Richard Mayeux (USA)

Alzheimer's Disease and Parkinson Disease in population-based studies involving superold

Carol Brayne (UK)

The study of epilepsy in developing countries: the role of different culture

Pierre Marie Preux (France)

ALS: the study of a rare disease in population-based setting

Giancarlo Logroscino (Italy)

Topic 9 (Tue 24/9) Environment, Climate Change (convenors: Gustavo C. Roman , USA, Jacques Reis , France) A presentation of the World Federation of Neurology’s Applied Research Group on Environmental Neurology

(Chair: Gustavo Roman, USA) Tuesday, September 24, 2013 at 09:00 - 10:30

T9.1 Session 1: Environmental Neurology

MCS - “Multiple chemical sensitivity”

Jacques Reis (France)

Stroke and air pollution

Valery Feigin (New Zealand)

From nose to Brain, historical approach and recent developments in Parkinsonism

Lucchini Roberto (Italy) (replaced Frederick Gay (UK)

12

T9.2 Session 2: Climate and the global change

(Chair: Jacques Reis, France)

The west Nile virus story

Gustavo Roman (USA)

The No-input Syndrome: from space to patient Franz Gerstenbrand (Austria)

Neurological consequences of radiation: the Japanese example

Yoshikazu Ogawa (Japan)

Topic 10 (Mon 23/9) T10 (14:45 - 16:15) Autonomic Nervous System (Convenor: Roy Freeman (USA)

A presentation by the World Federation of Neurology’s Applied Research Group on Autonomic Disorders

Chair: Roy Freeman (USA)

Central and peripheral autonomic disorders

Eduardo Benarroch (USA)

Standard and novel tests of autonomic function

Roy Freeman (USA)

Genetic autonomic disorders

Pietro Cortelli (Italy)

Assessment and treatment of urogenital function

Max Hilz (Germany)

Topic 11 (Tue 24/9) T11 Neuroophthalmology (Convenors, Chairs: Nancy J. Newman, Michael Halmagyi)

How Can the Clinical Bedside Examination of Eye Movements Inform the Neurologist?

Michael Halmagyi (Australia)

How Can Ocular Fundus Photography Inform the Neurologist?

Nancy J. Newman (USA)

How Can Optical Coherence Tomography (OCT) Inform the Neurologist?

Steven L. Galetta (USA)

How Can Venous Imaging Inform the Neurologist?

Valerie Biousse (USA)

Topic 12 (Wed 25/9) T12 Brain & Behavior (convenors: Fabrizio Benedetti, Facundo Manes)

A presentation by the World Federation of Neurology’s Applied Research Group on Aphasia and Cognitive Disorders Session: The dark continent between neurology and psychiatry (chair: Fabrizio Benedetti, Facundo Manes

How placebos change the patient's brain

Fabrizio Benedetti (Italy)

Apathy, irritability, psychosis - psychiatric symptoms in motor disorders

Thomas Bak (UK)

Psychiatric conditions that can mimic early behavioral variant Frontotemporal Dementia (bvFTD)

Facundo Manes (Argentina)

13

Topic 13 (Thu 26/9) Motor neuron disease (Convenors: Albert C. Ludolph,Germany, Gen Soboe, Japan)

A Presentation of the World Federation of Neurology’s Applied Research Group on Motor Neuron Disease

Thursday, September 26, 2013, 09:00 - 10:30

T13.1 Session 1: The Spectrum of Amyotrophic Lateral Sclerosis/Motor Neuron Disease (chair: Gen Soboe (Japan)

The neuropathology of Amyotrophic Lateral Sclerosis and Fronto-Temporal Dementia – Spectrum or distinct diseases

Manuela Neumann (Zürich)

Clinical spectrum and genetics of Kii A LS-PD complex

Shigeki Kuzuhara (Japan)

Cognition and other prognostic factors in Amyotrophic Lateral Sclerosis /Motor Neuron Disease

Albert Ludolph (Germany) T13.2 Session 2: Neurobiology of Amyotrophic Lateral Sclerosis/Motor Neuron Disease and their clinical implications

Thursday, September 26, 2013, 11:00 - 12:30

(chair: Albert Ludolph (Germany)

Phenotypic heterogeneity of ALS

Wim Robberecht (Belgium) Motor Neuron Disease in Young in India

M. Gourie-Devi

What can we learn from Kennedy´s Disease for Amyotrophic Lateral Sclerosis /Motor Neuron Disease

Gen Soboe (Japan)

Amyotrophic Lateral Sclerosis – one, two or multiple hits Speaker TBC

Topic 14 (Mon 23/9) T14 Palliative care (Convenor: Gian Domenico Borasio) A presentation of the World Federation of Neurology’s Applied Research Group on Palliative Care

Palliative care in neurology: principles and practice

Gian Domenico Borasio (Switzerland)

Palliative care and neurology: a global perspective

Raj Rajagopal (India)

ALS: a paradigmatic disease for neurological palliative care

Wendy Johnston (Canada)

Ethical issues in neurological palliative care

Ralf Jox (Germany)

Topic 15 (Tue 24/9) T15 Nutritional disorders & Neurotoxins (Convenors, Chairs: Marco T Medina, Nimal Senanayake )

Toxic disorders of the Nervous System

Desire Tshala-Katumbay (USA)

Malnutrition and Brain Development

Kenton Holden (USA)

Neurologic Consequences of Malnutrition

Marco T Medina (Honduras)

Disorders of the neuromuscular junction caused by naturally occurring neurotoxins

Nimal Senanayake ( Sri Lanka)

14

Topic 16 (Tue 24/9) T16 Stem cells in neurology: hopes, uses and abuses (convenors: Gianvito Martino)

Stem cell transplantation in Parkinson’s disease 30 years later

Olle Lindvall (Sweden)

Stem cell therapy in inflammatory neurological disorders

Gianvito Martino (Italy)

Neural stem cells as a therapeutic tool in spinal cord injury

Armin Curt (Switzerland)

Topic 17 (Tue 24/9) T17 Neurosurgery for Neurologists ( Convenors: F Tomasello, Italy, Peter Black, USA )

Joint World Federation of Neurosurgical Societies / World Federation of Neurology Session

'Neurological syndromes in bulbar compression by an ectatic vertebral artery

Francesco Tomasello (Italy)

Neurosurgical Contributions to Mapping the Human Brain

Peter Black (USA)

Seizures and surgical management of low grade gliomas

Hugues Duffau (France)

The potential of Deep Brain Stimulation in diseases of the brain

Andres M. Lozano (Canada)

Topic 18 (Wed 25/9) T18 Psychiatry for the Neurologist: Theoretical and clinical implications Joint World Psychiatric Association / World Federation of Neurology Session (Convenors Levent Kuey Turkey, Mostafa El Alaoui Faris)

Chair:Levent Kuey Turkey, Mostafa El Alaoui Faris, Morocco

Neurobiology in Psychiatry

Andreas Heinz (Germany)

Somatoform Disorders

Mostafa El Alaoui Faris (Morocco)

Catatonia

Steve Laureys (Belgium)

Depressive disorders: challenges in classification and clinical practice

Levent Kuey (Turkey)

Topic 19 (Thu 26/9) T19 Neuroethics (Convenor and Chair: James L. Bernat USA) Ethical issues in neuroscience research

Eric Racine (Canada)

Philosophical issues in consciousness

Adam Zeman (UK)

Brain death: ethical issues

James Bernat (USA)

End-of-life issues in neurology

Gian Domenico Borasio (Switzerland)

15

Topic 20 (Tue 24/9) T20 (11:00 - 12:30) Interventional Neuroradiology (Convenors: Werner Hacke, Germany, Pedro Lylyk, Argentina) Chairs: Werner Hacke Germany, Pedro Lylyk Argentina

New techniques and data in the interventional therapy of ruptured and unruptured complex and giants aneurysms

Pedro Lylyk (Argentina)

The need of randomized evidence for recanalization devises - a general statement

Werner Hacke (Germany)

Status and preliminary results of IMS III

Joe Broderick (USA) SWIFT, a randomized comparison between merci and solitaire

Osama Zaidat (USA)

Topic 21 (Wed, Sept 25, 16:30 - 18:00 ) T21 Advances in Neuroimaging (Convenors: Joseph C. Masdeu (USA)

A presentation of the World Federation of Neurology’s Applied Research Group on Neuroimaging

Chair: J. Masdeu (USA) Advances in multiple sclerosis imaging

Massimo Filippi (Italy)

Conquering infection with the help of neuroimaging

Lazaro Amaral (Brazil)

High field MRI imaging at 7T

Tsutomu Nakada (Japan)

Movement disorders: MRI and PET

David J. Brooks (UK)

Unraveling the neurobiology of dementia with neuroimaging and genetics

Joseph C. Masdeu (USA)

Topic 22 (Thu 26/9) T22 (09:00 - 10:30) Advanced Neurophysiology (Convenor and chair: Paolo M. Rossini) Electroencephalography and brain connectivity

Claudio Babiloni (Italy)

Magnetoencephalography and brain connectivity

Stefan Teipel (Germany)

Transcranial magnetic stimulation and brain connectivity

Paolo M. Rossini (Italy)

Topic 23 (Sun 22/9) T23 (14:30 - 16:00) Therapeutic Neurotoxins (convenor and Chair: Cynthia Comella USA) Expanding applications of botulinum toxin

Marcelo Merello (Argentina)

Comparative trials of botulinum toxins

Cynthia Comella (USA)

The challenge of botulinum treatment for spasticity

Ryuji Kaji (Japan)

Topic 24 (Mon 23/9)

T24 Biomarkers (convenor: Gavin Giovannoni) Chair: Florian Deisenhammer ( Austria)

The role of biomarkers for monitoring the course of motor neuron disease

Andrea Malaspina ( UK)

The impact of biomarkers on the definition and outcome of multiple sclerosis

16

Florian Deisenhammer ( Austria)

The role of biomarkers in the diagnosis and treatment of Alzheimer’s disease

Kaj Blennow ( Sweden)

Using biomarkers to diagnosis Parkinson’s disease in the pre-motor stage

Daniela Berg ( Germany)

Topic 25 (Thu 26/9) T25 (11:00 - 12:30) YouTube neurology (Convenor: Tony Lang Canada) Chair: Tony Lang Canada

Movement Disorders

Tony Lang (Canada)

Stroke and general neurology

Jose Biller (USA)

Pediatric neurology

Marc Patterson (USA) Wiggly Eyes: Spot that Oscillation

John Leigh (USA)

Topic 26 (Wed 25/9) T26 (14:30 - 16:00) Movies and neurology (Convenor and speaker: Jordan Topel)

Jordan Topel (USA)

Topic 27 (Tue 24/9) T27 Sports Neurology Session (Convenor and Chair: Mark Hallett USA) Concussion: mechanism and acute management

Jeffrey Kutcher (USA)

Concussion: chronic management and second impact syndrome

Barry Jordan (USA)

Peripheral nerve injuries

Mark Hallett (USA)

Cervical spine injury

Volker Dietz, Switzerland

Topic 28 (Wed 25/9) T28 Training in Neurology around the World (Convenor and Chair: Wolfgang Grisold) Education as an impact in the health system

Marco T. Medina (Honduras)

Educational structures in Asia

Man Mohan Mehndiratta (India)

The needs in African education

Amadou Gallo Diop (Senegal)

Subspecialization - a new development in neurology

Stephen Sergay (USA)

Certification and harmonization in Europe

Wolfgang Grisold (Vienna, Austria)

17

Topic 29 (Monday 23/9) 11:15-12:45

T29 World Health Organization Neurology Initiatives (convenors: Tarun Dua Switzerland, Donna Bergen USA) Non-Communicable Disease Initiative

Tarun Dua (India)

mhGAP Programme, Closing the Mental Health Gap

Shekhar Saxena (Switzerland)

Revising the ICD-10

Raad Shakir (UK)

The World Brain Alliance – Speaking Up for Brain Health

Vladimir Hachinski (Canada)

Topic 30 (Tue 24/9) T30 Evolution in Neurology (Convenor and Chair: George K. York USA) A presentation by the World Federation of Neurology’s Research group on the History of the Neurosciences

Introduction and Welcome

George K. York III (USA)

Evolution in Ancient and Galenic Medicine

Axel Karenberg (Germany)

Darwinian and Jacksonian Evolution

David A. Steinberg (USA)

Evolution in Neurology in the 20th Century...and the 21st

George K. York II (USA)

Topic 31 (Sunday, September 22) Making the Case for Neurology (Convenors: Donald Silberberg (USA), Jes Olesen Denmark) 09:00 - 10:30

T31.1 Session 1: (chair: Donald Silberberg USA)

The Global Burden of Disease – Advocacy via Epidemiology

Gretchen Birbeck (Zambia)

The Cost of Neurological Disorders in Europe – Advocacy via Finances

Jes Olesen (Denmark)

The Cost of Neurological Disorders in Low Income Countries – Advocacy via Finances + Human Capital

Donna Bergen (USA)

Do the Data Influence Public Policy?

Barbara Vickrey

T31.2 Session 2: (Chairs: Jes Olesen, Barbara Vickrey ) 11:00 - 12:30

Decade of the Brain to 2013 – Advocacy Progresses

Donald Silberberg (USA)

Influencing the Government in a Middle Income Country

Marcelo Cruz (Ecuador)

Influencing the Government in a Low Income Country

Elly Katabira (Uganda)

The Promise of Social Networking

Audrey Craven (Ireland) T31.3 Session 3 (proposed EFNA, Chair: Donald Silberberg, Najoua Miladi, Tunisia (TBC) 14:30 - 16:00

Introduction – setting the scene

Jes Olesen (Denmark)

18

Case Study 1: The Dystonia Coalition

H. A. Jinnah (USA)

Case Study 2: The Neurological Alliance of Ireland

Mary Harney (Ireland)

Case Study 3: The Parkinson’s Disease and Movement Disorder Society, India

Maria Barretto (India)

Topic 32 (Monday, September 23, 16:45 - 18:15) T32 Tropical Neurology (Convenors: Amadou Gallo Diop, Pierre-Marie Preux) Dementia in tropical areas, a future public health challenge?

Touré Kamadore (Senegal)

Stroke in tropical countries: prevention and management

Marco Medina (Honduras)

Neurological complications of dengue

JMK Murthy (India)

Epilepsy in Africa: current situation and next steps in the situation of globalization

Amadou Gallo Diop (Senegal)

Topic 33 (Wed 25/9) T33 (11:00 - 12:30) Neuro-Otology and Neuro-Ophthalmology (Convenors: John Leigh USA, Michael Halmagy

Australia) Session: Evaluation and Management of Vertigo, Nystagmus and Visual Disturbances (chair: Prof: G. Michael Halmagyi)

Evaluation and management of the patient with unilateral and bilateral peripheral vestibular disturbances

G. Michael Halmagyi (Australia)

Evaluation and management of central vestibular disturbances and nystagmus

R. John Leigh ( USA)

New approaches to treating visual defects and nystagmus

Christopher Kennard ( UK)

19

Debate 1 (Mon 23/9: 16:45 - 18:15) Movement Disorders (Chair: Werner Poewe )

Topic A: DBS should be considered as soon as fluctuations occur

Yes: Guenther Deuschl (Germany)

No: Olivier Rascol (France)

Multiple Sclerosis (Chair: Bill Carroll)

Topic B: Clinicians rate risk of disabling MS less than risk of effective treatment

Yes: Christoph Heesen (Germany)

No: Dan Ontaneda (USA)

Debate 2 (Tue 24/9: 16:30 - 18:00) Stroke (Chair: Werner Hacke)

Topic A: It is ethical to test recanalization devices in placebo controlled trials

Yes: Steve Davis (Australia)

No: Heinrich Mattle (Switzerland)

Epilepsy (Chair: Pete Engel) Topic B: Treatment options and outcomes for epilepsy continue to improve

Yes: Meir Bialer

No: Dale Hesdorffer

20

Regional Session 1 (22/9 14:30 - 16:00)

AOAN (Asian Oceanian Association of Neurology) Chairs: Man Mohan Mehndiratta (India), C.P.Tsai (Taiwan)

Current Status of Research and advances in Neurological Disorders in Asian Oceanian region Introduction: Man Mohan Mehndiratta (India) 1. Status of research in Neurology in Asian Oceanian region- Lawrence KS Wong (Hong Kong) 2. CNS Bugs and Stroke - Man Mohan Mehndiratta(India) 3. CNS Infections in East and West - Mohammad Wasay (Pakistan) 4. Improving Stroke care in Asian Oceanian region - Stephen M Davis (Australia) Concluding Remarks: C.P.Tsai & Man Mohan Mehndiratta

Regional Session 2 (22/9 16:30 - 18:00)

Africa

Chair: Riadh Gouider The proposed title of the session is “CHALLENGING NEUROPATHIES”: 1. Neuropathy screening in Africa - Thérèse SONAN 2. Inherited focal neuropathies - Riadh GOUIDER 3. Diabetic neuropathies - Eva FELDMAN 4. Infectious neuropathies - Mehila ZEBENIGUS

Regional Session 3: (Wednesday, September 25, 16:30 - 18:00)

Europe Stroke: the view from Europe Chairs Richard Hughes, London, UK (President EFNS) Claudio Bassetti, Bern, Switzerland (President ENS) 1. Update on evidence-based treatment and prevention of stroke - Peter Sandercock, Edinburgh, UK 2. The expected challenge of stroke during the next decade - Maura Pugliatti, Sassari, Italy 3. Research is the way to improve treatment for brain disorders - Philippe Cupers, Brussels, Belgium - EU

Regional Session 4 (25/9 at 09:00-10:30)

PAUNS

Chair: Ahmad Khalifa 1. Cognitive effects of cardiac surgery in Syria - Ahmad khalifa 2. Managment of Nonconvulsive status epilepticus - Hassan Hosny 3. Recessive ataxias - Chokri Mhiri

Regional Session 5 (Wednesday, September 25, 14:30 - 16:00) Latin America Chair: Marco T Medina 1. MS in Latin America - Jorge Correale (Argentina) 2. Juvenile Myoclonic Epilepsy in Brazil - Elza Marcia Yacubian (Brazil) 3. Vascular dementia among hyspanics - Gustavo Roman (USA/Columbia) 4. Community interventions to Reduce Epilepsy due to Neurocysticercosis in Latin America - Marco T Medina

21

PLENARY LECTURES

Sunday Sept 22 1. Vienna and the Age of Insight - Eric Kandel, Canada 2. Advances in childhood epilepsy - Jo Wilmshurst, South Africa

Monday Sept 23 1. B Singhal lecture: Neurology of aging - Ayrton Massaro, Brazil 2. Victor and Clara Soriano Lecture: Recanalization in Acute Ischemic Stroke - Werner Hacke, Germany

Tuesday Sept 24 1. Autoantibodies and CNS disease - Angela Vincent, UK 2. Vascular cognitive impairment - Christopher Chen, Singapore

Wednesday Sept 25 1. Fulton Symposium Soriano Lecture: Impact of genetics on the field of neurology - John Hardy, UK 2. Towards a redefinition of Parkinson’s Disease - Werner Poewe, Austria

Thursday Sept 26

1. James Parkinson - Gerald Stern, UK 2. Masland Lecture: CNS Tuberculosis – a global challenge - Sarosh M. Katrak, India